Dusseldorf, Germany (PRWEB) October 28, 2009
The XCell-Center, Europe's leading adult stem cell therapy center, is proud to announce that it is now treating heart patients from around the world with autologous bone marrow stem cells at its new facility in Dusseldorf Germany.
This new treatment presents a viable alternative for heart patients who have exhausted standard treatment options or are opposed to undergoing invasive treatments like coronary artery bypass grafting (CABG).
"I no longer have any angina pain or shortness of breath; no symptoms whatsoever. I am walking 3 miles per day and lifting heavy weights again. I consider this a complete reversal. I saw my cardiologist 2 weeks ago for more testing and he is still shaking his head!" exclaimed Aaron Wood five months after treatment. Mr. Wood was suffering from heart failure following three heart attacks and was treated at the XCell-Center's Dusseldorf clinic in May 2009.
The treatment begins by collecting a small amount bone marrow from the patient's hip bone using a thin needle under local anesthesia. The stem cells ae then separated from the bone marrow at the XCell-Center's EU certified cGMP laboratory (current good manufacturing process). Before the cells leave the lab, they are counted and their vitality is confirmed. The last step of the treatment is the minimally invasive implantation procedure, which consists of inserting a cardiac catheter into the patient's right femoral artery and then guiding it to the heart where the stem cells are released into the coronary arteries.
"We are offering heart patients a practical, affordable and State of the Art therapy . We know that autologous stem cell therapy can improve their quality of life and Mr. Wood is a perfect example. Patients like Mr. Wood no longer need to wait for 'treatments of the future'. They can undergo stem cell-based heart treatments at our world-class treatment facility in Dusseldorf, German today," said Dr. Cornelis Kleinbloesem, the XCell-Center's Director.
The cost of the XCell-Center heart treatment is 11,500 Euros. Patients suffering from ischemic or non-ischemic cardiomyopathy who have a diminished left ventricular function may qualify for this life-changing treatment.
Bone marrow stem cells have been used to treat thousands of heart patients around the world. Autologous adult bone marrow treatments are the focus of dozens of promising clinical trials in the United States, Europe, Japan and South America.
About the XCell-Center
The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first privately-owned clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law and European guidelines. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.
The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson's, Alzheimer's and several eye diseases.
For more information on Stem Cell Therapy:
XCell-Center Website: http://www.xcell-center.com
at the Institute for Regenerative Medicine
Am Heerdter Krankenhaus 2
40549 Dusseldorf, Germamy
Phone: 1-866-680-8202 (USA Toll-Free) (+49) 0221-802-5095 (Germany)
Fax: 1-713-583-9322 (USA) (+49) 0221-2921-2550 (Germany)
# # #